BRANFORD, Conn., May 05, 2016 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in non-invasive patient monitoring of cerebral oxygenation, today reported financial results for the three months ended March 31, 2016.
Net sales from continuing operations increased 21% to $5.5 million for the first quarter of 2016, from $4.5 million for the first quarter of 2015.
Total sales, including sales from discontinued operations, were $6.1 million for the first quarter of 2016. In October 2015, CASMED sold assets related to its 740 SELECT® vital signs monitoring product line, and in March 2016, the Company sold assets related to its neonatal intensive care disposables product line. Both of those businesses are accounted for as discontinued operations.
Net sales from continuing operations increased 21% to $5.5 million for the first quarter of 2016, from $4.5 million for the first quarter of 2015.
Total sales, including sales from discontinued operations, were $6.1 million for the first quarter of 2016. In October 2015, CASMED sold assets related to its 740 SELECT® vital signs monitoring product line, and in March 2016, the Company sold assets related to its neonatal intensive care disposables product line. Both of those businesses are accounted for as discontinued operations.
